MPHP2201, mphp-2201 – Research Chemicals Vendor

MPHP-2201: A Detailed Overview for Researchers

MPHP-2201, also referred to as mphp-2201, is a synthetic cannabinoid from the indole-based class of compounds. Known for its structural similarity to other synthetic cannabinoids such as 5F-MDMB-PINACA and NM-2201, MPHP-2201 has gained significant attention in the scientific community for its potent effects on cannabinoid receptors and potential applications in pharmacological research.

While MPHP-2201 is not approved for human consumption, its study has contributed to a better understanding of the cannabinoid receptor system and its broader implications for therapeutic applications.

---

Chemical Properties of MPHP-2201

• IUPAC Name: 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide
• Chemical Formula: C23H27FN2O
• CAS Number: Not widely documented in public chemical registries.
• Appearance: Generally available as a fine white or off-white powder.

---

How MPHP-2201 Works

MPHP-2201 is a potent agonist of the CB1 and CB2 cannabinoid receptors, similar to THC but significantly more potent. It interacts with the endocannabinoid system, producing strong pharmacological effects that have made it a subject of interest in laboratory settings.

---

Applications in Research

Synthetic cannabinoids like MPHP-2201 are invaluable in cannabinoid-related research. Common applications include:

1. Pharmacological Studies: Understanding how synthetic cannabinoids interact with CB1 and CB2 receptors.
2. Therapeutic Potential: Exploring potential medical uses for cannabinoid receptor agonists in conditions such as pain management or neurological disorders.
3. Toxicology and Metabolism: Studying the metabolism and toxicological effects of synthetic cannabinoids in biological systems.

---

Health and Safety Concerns

Potential Risks:

MPHP-2201, like other synthetic cannabinoids, has been associated with:

• Severe psychoactive effects.
• Increased heart rate (tachycardia).
• Hypertension and cardiovascular risks.
• Neurological symptoms such as agitation, confusion, and seizures.
• Respiratory depression in extreme cases.

Addiction Potential:

Prolonged exposure to MPHP-2201 can result in tolerance and dependency, leading to withdrawal symptoms if use is abruptly ceased.

---

Legal Status of MPHP-2201

The legal classification of MPHP-2201 varies globally:

• United States: MPHP-2201 is likely covered under the Federal Analogue Act, making it illegal if intended for human consumption.
• European Union: Many EU countries have banned MPHP-2201 and similar synthetic cannabinoids due to health concerns.
• Asia and Other Regions: Regulatory approaches differ widely, with some countries listing it as a controlled substance.

Researchers must ensure compliance with local and international laws when acquiring and handling MPHP-2201.

---

Sourcing MPHP-2201 for Research

When selecting a research chemical vendor, it’s crucial to prioritize:

1. Purity: High-quality MPHP-2201 ensures accurate and reproducible research results.
2. Documentation: Certificates of analysis (COAs) guarantee product authenticity.
3. Compliance: Vendors should adhere to all applicable laws and regulations.

Reputable vendors prioritize ethical practices, secure packaging, and reliable shipping to maintain the integrity of the product during transit.

---

Conclusion

MPHP-2201 represents a potent and versatile tool for studying the cannabinoid receptor system and its pharmacological implications. However, due to its potency and associated risks, it must be handled responsibly in controlled laboratory environments.

Disclaimer: This article is for informational purposes only. MPHP-2201 is a controlled substance in many jurisdictions. Researchers must comply with local laws and regulations when working with synthetic cannabinoids.

Keywords: MPHP-2201, mphp-2201, synthetic cannabinoids, research chemicals vendor, CB1 receptor, CB2 receptor, cannabinoid receptor agonists, MPHP-2201 legality, MPHP-2201 research.